ROMEOVILLE, IL, March 15, 2024 (Globe Newswire) — Nanophase Technologies Announces Fourth Quarter and Year End of 2023 Financial release and conference call details
NanoPhase Technologies Corporation (OTCQB: NANX) is a developer of mineral-based, evidence-based healthcare solutions across beauty and life science categories with innovations that protect skin from environmental aggressors and aid in medical diagnostics. Leader, the company announced today that its fourth quarter 2023 financial news release will be released after market close on Wednesday, March 20, 2024, followed by an investor conference call scheduled for Thursday, March 21.
Q4 2023 Conference Call
Nanophase will hold a fourth quarter conference call on Thursday, March 21, 2024 at 10:00 a.m. CDT, 11:00 a.m. EDT to discuss financial results and provide business and financial updates. The conference call will be joined by Jess Jankowski, the Company's President and CEO, and Kevin Cureton, the Company's Chief Operating Officer.
Participant registration:
https://register.vevent.com/register/BI8a78cf9c18bd4fb9970136859214e9cd
You must register at the link above to receive a dial-in number and personal PIN. When you register, you also have the option to dial out from the system after the conference call begins. If you forget her PIN before the conference call, you can easily re-register it.
The process for listening-only access to a webcast remains the same. You can access the replay after the call using the same link. Telco replay is no longer available.
Listen-only webcasts and replays:
https://edge.media-server.com/mmc/p/cz7zx2q2/
Connect to the meeting at least 5 minutes before the call is scheduled to start.
The call can also be accessed through the company's website. www.nanophase.com“Investor Relations,'' “Investor News,'' and the links in this conference call announcement release.
About nanophase technology
Nanophase Technologies Corporation (OTCQB: NANX), www.nanophase.com, is a leading innovator of mineral-based, evidence-based healthcare solutions across the beauty and life sciences categories, as well as other traditional advanced materials applications. We leverage a platform of integrated, patented, proprietary technologies to create products with unique performance that improve the health and well-being of consumers. We offer commercial quantities and high quality processed materials in a variety of formats, both as raw materials and as part of fully formulated products.
###
Investor Information Contact:
Phone: (630) 771-6736
